January 07, 2008 at 13:19 PM EST
Mid-Day Report

The markets traded higher during the midday with the Dow climbing 42 points to 12,842. Nasdaq added 7 points to 2512.

On the upside

InterMune (Nasdaq: ITMN) will begin a two week triple combination trial of its chronic hepatitis C treatment ITMN-191.

Biolase Technology (Nasdaq: BLTI) selected Jake St. Philip to be its new chief executive and provided fourth quarter guidance in line with expectations.

Investment fund Breeden Capital Management increased its stake in Zale (NYSE: ZLC) to 7.1 million shares or approximately 15.9%.

On the downside

ShoreTel (Nasdaq: SHOR) blamed lower sales for warning that second quarter results will fall short of expectations.

Avocent (Nasdaq: AVCT) forecast fourth quarter revenue below expectations saying that sales in North America dropped.

Jefferies Group (NYSE: JEF) warned of significant losses for the fourth quarter.

In the broad market, advancing issues outpaced decliners by a margin of 3 to 2 on the NYSE and by nearly 5 to 4 on Nasdaq. The Russell 2000 which tracks small cap stocks gained 8 points to 729.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here